Biotechnology
If You're in Neurocrine Biosciences Consider Getting Out: Here's Why
Let's check the charts and indicators.
Here Are 2 Ways I'm Playing the Market With Small-Cap Stocks
I'm going both ways in what I view as an overbought market within a deteriorating economy.
I Found a Good-Looking Arrowhead in This Biotech ETF
Let's review the charts of XBI, the SPDR S&P Biotech ETF.
Does Intellia Therapeutics Stock Have Good Genes?
Let's check on the charts and indicators of the cutting-edge CRISPR editing company.
Amgen Is Casting a Bearish Technical Hue in Advance of Earnings
The biotech giant's charts have displayed weakness of late as it prepares to report fourth-quarter results.
Johnson & Johnson Might Need a Band-Aid Ahead of Earnings
A rally in the shares stalled around $180 in December and early January.
Bearish Bets: 3 Nasdaq Giants You Should Think About Shorting This Week
These stocks are displaying bearish tendencies based on their technical patterns.
This Small Pharma Company Could Develop Into a Nice Trade
Let's see how to trade GlycoMimetics, a clinical-stage drug developer focused on a type of cancer treatment.
Incyte Gets a Quantitative Upgrade
We have two price target areas for this biopharmaceutical firm.
Why Are Insiders Buying These 2 Stocks?
An oncology and a oil & gas concern, new names on my list, have my attention.